Company Update: CARBOGEN AMCIS introduces SPRINT for early-phase development
A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour.
CARBOGEN AMCIS has launched SPRINT, a dedicated approach to early-phase drug substance development designed to deliver faster, more efficient progression to clinical phases without compromising scientific rigour.
As pressure on early development continues to mount, with tighter timelines, milestone-driven funding models and growing complexity, SPRINT has been designed to provide a more focused, fit-for-purpose way of working.
SPRINT combines multidisciplinary expertise with agile execution to support early-phase programmes through activities such as route scouting, process development and early GMP phases readiness. It is intended for biotech and pharmaceutical companies seeking a partner that can act as an extension of their team, providing clear guidance, rapid decision-making and aligned execution from the outset. By focusing on what is truly required at this stage, it avoids unnecessary complexity while maintaining full compliance and uncompromised safety standards.
By bringing experience from later development stages into the earliest phases, SPRINT helps anticipate future requirements, reduce rework, and enable more reliable progression through key development milestones.
“SPRINT builds on CARBOGEN AMCIS’ long-standing expertise in early-phase development, combining scientific excellence with a strong track record of efficient delivery,” said Marc Lanz, Senior Head of Innovation. “We know how to solve complex challenges early and how to do it right the first time, with long-term success in mind.”
“Early-phase development requires more than speed; it requires smart decisions,” added Martin Althaus, Manager PR&D. “With this approach, we bring later-stage experience into the earliest phases, enabling fast, reliable and truly phase appropriate solutions.”
SPRINT is now available as part of CARBOGEN AMCIS’ Drug Substance services.
For further information about SPRINT visit www.carbogen-amcis.com/sprint
Or download the SPRINT brochure below: